Heart Transplantation

Displaying 151 - 157 of 157CSV
Clerkin, K. J., Griffin, J. M., Fried, J. A., Raikhelkar, J., Jain, R., Topkara, V. K., Habal, M. V., Latif, F., Restaino, S., Colombo, P. C., Takeda, K., Naka, Y., Farr, M. A., Sayer, G., & Uriel, N. (2021). How can we better inform our patients about post‐heart transplantation survival? A conditional survival analysis. Clinical Transplantation, 35(11). Portico. https://doi.org/10.1111/ctr.14449
Publication Date
Giangreco, N. P., Lebreton, G., Restaino, S., Jane Farr, M., Zorn, E., Colombo, P. C., Patel, J., Levine, R., Truby, L., Soni, R. K., Leprince, P., Kobashigawa, J., Tatonetti, N. P., & Fine, B. M. (2021). Plasma kallikrein predicts primary graft dysfunction after heart transplant. The Journal of Heart and Lung Transplantation, 40(10), 1199–1211. https://doi.org/10.1016/j.healun.2021.07.001
Publication Date
Bracamonte-Baran, W., Gilotra, N. A., Won, T., Rodriguez, K. M., Talor, M. V., Oh, B. C., Griffin, J., Wittstein, I., Sharma, K., Skinner, J., Johns, R. A., Russell, S. D., Anders, R. A., Zhu, Q., Halushka, M. K., Brandacher, G., & Čiháková, D. (2021). Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8+ T-Cell Infiltration After Heart Transplantation. Circulation: Heart Failure, 14(10). https://doi.org/10.1161/circheartfailure.120.007982
Publication Date
Slomovich, S., Oh, K. T., Diakos, N. A., Restaino, S. W., Clerkin, K. J., Latif, F., Miyauchi, J. T., Lee, A., Sayer, G. T., & Uriel, N. (2021). A Rare Case of Disseminated Tuberculosis and Hematological Malignancy in a Heart Transplant Recipient. Transplantation Proceedings, 53(8), 2626–2629. https://doi.org/10.1016/j.transproceed.2021.07.037
Publication Date